ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Moses To Lead AACI.

October 19, 2001

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991